NPI: 1225227457 · NEW ORLEANS, LA 70119 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/24/2007
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 10/24/2007 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,523 | $22K |
| 2019 | 7,500 | $61K |
| 2020 | 3,644 | $0.00 |
| 2021 | 206 | $44K |
| 2022 | 1,273 | $142K |
| 2023 | 341 | $47K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 2,219 | 370 | $303K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 11,150 | 729 | $12K |
| 83970 | 417 | 338 | $0.00 | |
| 85048 | 579 | 486 | $0.00 | |
| 85041 | 579 | 486 | $0.00 | |
| 83540 | 320 | 238 | $0.00 | |
| 82108 | 159 | 122 | $0.00 | |
| 82746 | 151 | 111 | $0.00 | |
| 82728 | 342 | 258 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 1,697 | 790 | $0.00 |
| 82607 | 130 | 93 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 48 | 44 | $0.00 |
| 83550 | 335 | 251 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 304 | 43 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 57 | 48 | $0.00 |